美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vivos Inc.

0.0880

-0.0020-2.22%

成交量：19.12萬

成交額：1.68萬

市值：4,001.05萬

市盈率：-12.76

高：0.0895

開：0.0888

低：0.0840

收：0.0900

52周最高：0.1657

52周最低：0.0425

股本：4.55億

流通股本：4.34億

量比：0.40

換手率：0.04%

股息：- -

股息率：- -

每股收益(TTM):-0.0069

每股收益(LYR):-0.0043

淨資產收益率：-178.25%

總資產收益率：-96.45%

市淨率：-5.58

市盈率(LYR):-20.49

資料載入中...

總覽公司新聞資訊公告

Vivos Inc. 宣佈在向FDA提交Radiogel®精準放射性核素療法™研究器械豁免申請方面取得重大進展

Vivos Inc.聘請頂級FDA監管專家約翰·J·史密斯博士支持Radiogel®的IDE提交

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RDGL/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RDGL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RDGL\",,,,,undefined,":{"symbol":"RDGL","market":"US","secType":"STK","nameCN":"Vivos Inc.","latestPrice":0.088,"timestamp":1774287742725,"preClose":0.09,"halted":0,"volume":191214,"delay":15,"changeRate":-0.022222222222222244,"floatShares":434000000,"shares":454664957,"eps":-0.006898,"marketStatus":"交易中","change":-0.002,"latestTime":"03-23 13:42:22 EDT 延時","open":0.08875,"high":0.0895,"low":0.084,"amount":16811.450400000005,"amplitude":0.061111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.006898,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.09,"volumeRatio":0.401864},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RDGL\",,,,,undefined,":{"symbol":"RDGL","floatShares":434000000,"roa":"-96.45%","roe":"-178.25%","lyrEps":-0.004295,"volumeRatio":0.401864,"shares":454664957,"dividePrice":0,"high":0.0895,"amplitude":0.061111,"preClose":0.09,"low":0.084,"week52Low":0.0425,"pbRate":"-5.58","psRate":"822.89","week52High":0.1657,"institutionHeld":0,"latestPrice":0.088,"eps":-0.006898,"divideRate":0,"volume":191214,"delay":15,"ttmEps":-0.006898,"open":0.08875,"prevYearClose":0.0689,"prevWeekClose":0.09,"prevMonthClose":0.0849,"prevQuarterClose":0.0689,"fiveDayClose":0.0866,"twentyDayClose":0.083,"sixtyDayClose":0.0689},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RDGL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-13","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-09","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-18","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-11-06","symbol":"RDGL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1699246800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RDGL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RDGL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RDGL\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172695555","title":"Vivos Inc. 宣佈在向FDA提交Radiogel®精準放射性核素療法™研究器械豁免申請方面取得重大進展","url":"https://stock-news.laohu8.com/highlight/detail?id=1172695555","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172695555?lang=zh_tw&edition=fundamental","pubTime":"2026-02-10 21:33","pubTimestamp":1770730414,"startTime":"0","endTime":"0","summary":"Vivos Inc. 近日宣布，公司在为其核心产品Radiogel®精准放射性核素疗法™向美国食品药品监督管理局（FDA）提交研究器械豁免（IDE）申请的工作中，取得了显著进展。这一关键里程碑标志着该疗法向临床应用迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RDGL","BK4082"],"gpt_icon":0},{"id":"1185565667","title":"Vivos Inc.聘請頂級FDA監管專家約翰·J·史密斯博士支持Radiogel®的IDE提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1185565667","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185565667?lang=zh_tw&edition=fundamental","pubTime":"2025-10-27 20:30","pubTimestamp":1761568217,"startTime":"0","endTime":"0","summary":"Vivos Inc.聘请顶级FDA监管专家约翰·J·史密斯博士，以支持Radiogel®的IDE提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","RDGL"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}